ArticleFrontiers in immunology2023

Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.

Teresa Harthaller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.